1. Introduction
===============

Diabetic peripheral neuropathy (DPN) affects approximately 30% to 50% of all diabetic patients. Patients with DPN show a high morbidity of neuropathic pain, foot ulceration, amputation, and increased mortality.^\[[@R1]\]^ About 16% to 26% of people with diabetes suffer from painful peripheral neuropathy, which is characteristically more severe at night and often disturbs sleep.^\[[@R2]--[@R4]\]^ Numbness and loss of protective sensation in feet leads to foot ulceration, which affects around 15% to 25% of people with diabetes; 7% of those people with foot ulceration may require amputation within 10 years.^\[[@R5]\]^

According to the number of involved nerves, diabetic neuropathy can be briefly classified into mononeuropathy and polyneuropathy.^\[[@R6]\]^ Distal symmetric polyneuropathy is the most common sort of diabetic polyneuropathy, reflecting systemic factors not accessible to surgical management.^\[[@R7]\]^ Mononeuropathy may be associated with a combination of diabetes-induced nerve disorder and anatomic entrapment (the double crush).^\[[@R8],[@R9]\]^ Surgical decompression may be helpful in alleviating the neuropathic symptoms and reducing the incidence of foot ulceration/amputation of DPN patients by restoring the anterograde axoplasmic flow of the entrapped peripheral nerves.^\[[@R10]\]^

The current standard care for painful DPN (P-DPN) focuses on providing symptomatic relief by utilizing pharmacological interventions. Commonly used medications for P-DPN include, but are not limited to, tricyclic antidepressants, anticonvulsants (pregabalin and gabapentin), opioids, and tramadol (a weak opioid agonist).^\[[@R11],[@R12]\]^ Treatment of P-DPN must be accompanied by proper glycemic control for management of the underlying cause in diabetes.^\[[@R13]\]^ Administration of these regimens can be limited by a number of potential adverse side effects including triggering or worsening of mood disorders, lowered immunity, and development of addiction.^\[[@R13]\]^ Furthermore, these drugs do not alter the progression of DPN. In general, medical specialists emphasize medical management for the treatment of DPN, while surgical options are often overlooked.^\[[@R14],[@R15]\]^ They hold the standpoint that there is not enough evidence to support the use of surgical decompression in the treatment of DPN. The purpose of this study was to conduct a systematic review and meta-analysis of the literatures concerning the effect of surgical decompression procedures on symptomatic relief and sensory restoration of DPN patients, and provide recommendations for the future management of DPN.

2. Materials and methods
========================

2.1. Literature search
----------------------

Comprehensive literature searches of the following databases: PubMed--Medline, Ovid--Embase, and Cochrane Library were performed using a combination of database-specific subject headings and relevant text words or keywords. No limits were applied to the year of study. The Medical Subject Headings used were "diabetic neuropathy," "surgical decompression," and "outcomes." The following text words, keywords, and their combinations were also used: "diabetic patients," "peripheral nerve entrapment," "diabetic peripheral neuropathy," "symptomatic diabetic neuropathy," "painful diabetic neuropathy," "nerve decompression," "tunnel release," "surgical release," and "surgical treatment." The related articles function was used to broaden the search. A cross-reference search was also conducted to acquire the additional references. All retrieved records were added to an EndNote (Version X5, Thomson Reuter, New York, NY) library.

2.2. Study selection
--------------------

For all analyses performed in this review, studies were included only if they reported quantifiable outcomes of surgical decompression procedures in the treatment of DPN. Studies were excluded if they only provided unquantifiable outcomes of interest. The neuropathic symptoms of peripheral nerves in diabetic patients should be caused by diabetes mellitus. Studies were excluded if the peripheral neuropathy was caused by other factors. Besides, case reports, reviews, and animal studies were excluded.

2.3. Data extraction
--------------------

Two authors independently extracted the data of interest from each included study. Inconsistence was resolved after consultation with a third author. Relevant information, including first author, year of publication, research type, number of DPN patients, and operation site, were extracted. The outcomes of interest for our study included pain relief, sensory restoration, and complications of surgical procedures. Due to the different nerve entrapment sites in DPN patients, pooled data analysis of the effect of surgical treatment was conducted in the following ways: outcomes in upper-extremity nerves and outcomes in lower-extremity nerves.

2.4. Assessment of methodological quality
-----------------------------------------

The assessment of methodological quality was performed independently by 2 authors and inconsistence was resolved after consultation with a third author. The methodological index for nonrandomized studies^\[[@R16]\]^ was adopted for assessing the studies included in this review.

2.5. Statistical analysis
-------------------------

Analyses were performed with Review Manager (Version 5.3, The Nordic Cochrane Centre, the Cochrane Collaboration, Copenhagen, 2014). Mean differences and 95% confidence intervals (CIs) were calculated for continuous data. Chi-squared test was used for checking heterogeneity between studies and *I*^2^ showed the degree of heterogeneity. As to data with significant heterogeneity (*P* ≤ .1 and *I*^2^ ≥ 50%), random-effects model was used for pooled analysis. As to data without significant heterogeneity (*P* \> .1 and *I*^2^ \< 50%), fixed-effects model was used for pooled analysis. The significance of pooled data was further tested, and a *P* value of \< 0.05 was considered statistically significant. When enough studies were included, funnel plot delineated and the publication bias was evaluated.

2.6. Ethical approval
---------------------

This article does not contain any studies with human participants or animals performed by any of the authors, so there was not ethical approval in the study.

3. Results
==========

3.1. Literature search
----------------------

A total of 528 literatures were originally retrieved. After removal of duplicates, 208 literatures remained; 183 literatures, including case reports, reviews, and animal studies, were excluded. The full texts of the remaining 25 literatures were reviewed for eligibility. Of these 25 literatures, the data were overlapping or incomplete in 12 literatures and the causes of neuropathic symptoms were not limited to diabetes mellitus in 1 literature. Thus, 12 literatures (including 8 prospective and 4 retrospective) encompassing 1825 patients with DPN were included in the final analysis. The flowchart of literature search is shown in Fig. [1](#F1){ref-type="fig"}.

![Flowchart of literature search.](medi-97-e12399-g001){#F1}

3.2. Study characteristics
--------------------------

Only 1 out of the 12 literatures was identified as a randomized-controlled trial, in which the value of nerve decompression in the lower extremity of 40 patients with DPN was investigated.^\[[@R17]\]^ The remaining 11 literatures were observational, reporting either, prospectively or retrospectively collected data. In each study, surgical decompression was performed in either upper-extremity nerves or lower-extremity nerves of DPN patients. Seven of the observational studies were classified as upper-extremity nerve decompression group, in which a total of 176 diabetic patients with carpal tunnel syndrome (CTS) were included.^\[[@R18]--[@R24]\]^ The remaining 4 observational studies were classified as lower extremity nerve decompression group, in which a total of 1609 patients with neuropathic symptoms in the lower extremities were included.^\[[@R25]--[@R28]\]^ The basic characteristics and methodological quality of those literatures are shown in Table [1](#T1){ref-type="table"}.

###### 

Basic characteristics and methodological quality of included 12 literatures.
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3.3. Location of nerve decompression
------------------------------------

In the upper-extremity nerve decompression group, all the 176 patients (100%) had decompression of the median and ulnar nerves at the carpal tunnel. In the lower-extremity nerve decompression group, all the 1609 patients (100%) had decompression of the tibial nerve at the tarsal tunnel and 1583 patients (98%) had decompression of the common peroneal at the fibular head and the deep peroneal nerve at the dorsum of the foot.

3.4. Outcomes in upper-extremity nerves
---------------------------------------

Five studies including a total of 154 DPN patients assessed the effect of carpal tunnel release on symptomatic relief and functional restoration in the upper extremities through Boston questionnaire (BQ) score system.^\[[@R19],[@R21]--[@R24]\]^ As to symptomatic relief, pooled analysis showed a significant improvement (*P* \< .00001) by 1.77 on the BQ symptom severity (95% CI: 1.41--2.13) after surgery (Fig. [2](#F2){ref-type="fig"}). As to functional restoration, pooled analysis showed a significant improvement (*P* = .0002) by 1.39 on the BQ functional status (95% CI: 0.65--2.13) after surgery (Fig. [3](#F3){ref-type="fig"}).

![Pooled analysis of preoperative versus postoperative Boston questionnaire symptom severity in the upper extremities.](medi-97-e12399-g003){#F2}

![Pooled analysis of preoperative versus postoperative Boston questionnaire functional status in the upper extremities.](medi-97-e12399-g004){#F3}

Two studies including a total of 59 DPN patients assessed the changes of motor conduction velocity (MCV) of median nerve after carpal tunnel release.^\[[@R19],[@R20]\]^ Pooled analysis showed an improvement on MCV by 0.67 m/s (95% CI: −2.03 to 3.36 m/s) after surgery, but this was not statistically significant (*P* = .63) (Fig. [4](#F4){ref-type="fig"}). Three studies including a total of 81 DPN patients assessed the changes of sensory conduction velocity (SCV) and distal motor latency (DML) of median nerve after carpal tunnel release.^\[[@R18]--[@R20]\]^ As to SCV, pooled analysis showed a significant improvement (*P* = .009) by 6.44 m/s (95% CI: 1.63--11.25 m/s) after surgery (Fig. [5](#F5){ref-type="fig"}). As to DML, pooled analysis also showed a significant improvement (*P* = .03) by 1.36 milliseconds (95% CI: 0.14--2.58 milliseconds) after surgery (Fig. [6](#F6){ref-type="fig"}).

![Pooled analysis of preoperative versus postoperative motor conduction velocity of median nerve.](medi-97-e12399-g005){#F4}

![Pooled analysis of preoperative versus postoperative sensory conduction velocity of median nerve.](medi-97-e12399-g006){#F5}

![Pooled analysis of preoperative versus postoperative distal motor latency of median nerve.](medi-97-e12399-g007){#F6}

Two studies including a total of 59 DPN patients assessed the changes of MCV and DML of ulnar nerve after carpal tunnel release.^\[[@R19],[@R20]\]^ Pooled analysis showed an improvement on MCV by 0.16 m/s (95% CI: −1.69 to 2.00 m/s), and a deterioration on DML by 0.06 milliseconds (95% CI: −0.11 to 0.24 milliseconds) after surgery; however, both of them were not statistically significant (*P* = .87 and *P* = .48, respectively) (Figs. [7](#F7){ref-type="fig"} and [8](#F8){ref-type="fig"}).

![Pooled analysis of preoperative versus postoperative motor conduction velocity of ulnar nerve.](medi-97-e12399-g008){#F7}

![Pooled analysis of preoperative versus postoperative distal motor latency of ulnar nerve.](medi-97-e12399-g009){#F8}

3.5. Outcomes in lower-extremity nerves
---------------------------------------

Two studies including a total of 57 DPN patients assessed the effect of lower-extremity nerve decompression on neuropathic pain relief through visual analog scale (VAS).^\[[@R26],[@R27]\]^ Pooled analysis showed a significant improvement (*P* \< .00001) on VAS by 5.72 (95% CI: 4.99--6.44) after surgery (Fig. [9](#F9){ref-type="fig"}).

![Pooled analysis of preoperative versus postoperative visual analog scale in the lower extremities.](medi-97-e12399-g010){#F9}

Two studies including a total of 59 DPN patients assessed the effect of lower-extremity nerve decompression on sensory restoration through 2-point discrimination (2-PD).^\[[@R25],[@R26]\]^ Pooled analysis showed a significant improvement (*P* \< .00001) on 2-PD by 4.76 mm (95% CI: 3.38--6.14 mm) after surgery (Fig. [10](#F10){ref-type="fig"}).

![Pooled analysis of preoperative versus postoperative 2-point discrimination in the lower extremities.](medi-97-e12399-g011){#F10}

3.6. Complications of surgical procedures
-----------------------------------------

With regard to upper-extremity nerve decompression, 3 of the 7 observational studies included in our review reported the complications of carpal tunnel release operation.^\[[@R18],[@R19],[@R21]\]^ Zyluk and Puchalski reported 2 cases (4.9%) of superficial wound infection after operation, which resulted in recovery in 2 months.^\[[@R21]\]^ In the study by Mondelli et al, partial lesion of motor branch of median nerve was observed in 1 patient (4.2%) after operation.^\[[@R19]\]^ Similarly, Ozkul et al reported that 1 patient (4.5%) had median nerve laceration as a complication of carpal tunnel release operation.^\[[@R18]\]^

With regard to lower-extremity nerve decompression, 4 of the 5 studies included in our review reported the complications of surgical procedures.^\[[@R17],[@R25]--[@R27]\]^ The incidence of wound dehiscence was 12.5% and 12.1% in the study by Karagoz et al^\[[@R24]\]^ and Wood and Wood,^\[[@R26]\]^ respectively. As to superficial wound infection, the incidence was 5% and 15.4% in the study by Macaré van Maurik et al^\[[@R17]\]^ and Wieman and Patel,^\[[@R25]\]^ respectively. Besides, Macaré van Maurik et al reported 1 case of hematoma due to the use of anticoagulants,^\[[@R17]\]^ and Wieman and Patel reported that 1 patient who did not have a foot ulcer preoperatively developed an ulcer on a treated extremity.^\[[@R25]\]^

4. Discussion
=============

Not every diabetic patient with neuropathy should be considered for nerve decompression. Previously, diagnosis of diabetes and typical symptoms of DPN with nerve entrapment (asymmetric limb pain, numbness, diminished feeling, retarded tendon reflex, abnormal temperature, and vibration sensation), which cannot be relieved by medications, are strong indication for surgical decompression procedures. Besides, electrophysiological tests should be further performed to confirm the functional deficits of peripheral nerves in DPN patients. Specifically, the diagnosis of CTS in diabetic patients was based on clinical history and symptoms, and confirmed by median nerve conduction studies. It should be noted that in the lower extremities, chronic nerve entrapment is difficult to diagnose with traditional electrophysiological tests, thus a positive Tinel sign at the known site of anatomic narrowing is quite important to support the diagnosis.^\[[@R17],[@R25]--[@R28]\]^ The contraindications for surgical decompression procedures include peripheral neuropathy resulting from other defined factors (ischemia, cervical or lumbar spondylosis, narcotic drug, alcohol addiction, and other systemic or metabolic disorders); absence of motor/sensory potentials of peripheral nerves; and general health status unsuitable for surgery.

According to the article analysis in our review, the most frequent decompression surgery in upper extremity was carpal tunnel release for the entrapment of median nerve at wrist.^\[[@R18]--[@R24]\]^ In a standard carpal tunnel release surgery, a short (3--3.5 cm) longitudinal incision was made between the distal wrist and Kaplan cardinal line. The entire transverse carpal ligament was transected sharply and the distal 1 cm of the deep antebrachial fascia was split under direct vision. In general, additional procedures such as exploration of the thenar motor branch, flexor tenosynovectomy, or neurolysis were not necessary.^\[[@R29]\]^ Our meta-analysis of nonrandomized observational studies shows that carpal tunnel release significantly improves the BQ symptom severity and functional status of DPN patients in the upper extremities.^\[[@R19],[@R21]--[@R24]\]^ As to the changes in electrophysiological tests, our meta-analysis shows that the DML and SCV of median nerve of DPN patients are significantly improved after carpal tunnel release.^\[[@R18]--[@R20]\]^ However, based on our pooled analysis, the preoperative versus postoperative changes of MCV of median nerve are not statistically significant, as well as the preoperative versus postoperative changes of DML and SCV of ulnar nerve.^\[[@R19],[@R20]\]^

As to lower-extremity nerve decompression, surgical procedures included the decompression of deep and superficial peroneal nerve at foot, posterior tibial nerve at ankle, and common peroneal nerve at knee, as described by Zhong et al.^\[[@R28]\]^ Meta-analysis of the 4 nonrandomized observational studies shows that after surgical decompression procedures in the lower extremities, the improvement in neuropathic pain on VAS and the improvement in sensory restoration on 2-PD are considered clinically and statistically significant.^\[[@R25]--[@R28]\]^ Similarly, in the randomized-controlled trial included in our review, the VAS in the lower extremities was significantly improved after surgical decompression with a follow-up of 1 year.^\[[@R17]\]^ As to electrophysiological study, a prospective cohort study included in our review encompassing 1526 DPN patients showed significant improvement in nerve conduction velocity of the posterior tibial and common peroneal and superficial peroneal nerves.^\[[@R28]\]^ While it was reported in the randomized-controlled trial that decompression of lower-extremity nerves in DPN patients had no effect on electrophysiological tests 1 year after surgery.^\[[@R17]\]^

Seven studies included in our review reported the complications of surgical procedures.^\[[@R17]--[@R19],[@R21],[@R25]--[@R27]\]^ As to upper-extremity nerve decompression, the common complications after carpal tunnel release were superficial wound infection (incidence: 4.9% reported in 1 study^\[[@R21]\]^) and median nerve laceration (incidence: 4.2% and 4.5% reported in 2 studies^\[[@R18],[@R19]\]^). Compared with carpal tunnel release, the incidence of superficial wound infection after lower-extremity nerve decompression was relatively higher (5% and 15.4% reported in 2 studies^\[[@R17],[@R25]\]^). Besides, decompression procedures in the lower extremities also presented a relative high incidence of wound dehiscence after operation (12.5% and 15.4% reported in 2 studies^\[[@R26],[@R27]\]^). Unfortunately, the effect of surgical nerve decompression on prevention of ulceration and amputation in DPN patients could not be assessed in our review because of lack of sufficient data. A prospective multicenter study by Dellon et al^\[[@R30]\]^ demonstrated that in DPN patients with chronic tibial nerve entrapment, surgical decompression significantly reduced the incidence of ulceration and amputation in DPN patients.

The outcomes from the study by Dellon^\[[@R31]\]^ and Aszmann et al,^\[[@R10]\]^ which were not included in our review, demonstrated that the restoration of sensibility in upper-extremity nerves after nerve decompression procedures was significantly better than that in lower-extremity nerves. Besides, the nerve decompression procedures are more effective in the restoration of sensibility in upper extremity than that in lower extremity. Aszmann et al considered that the better improvement in the upper-extremity nerves postoperatively was most likely due to the patients with lower-extremity nerve decompression having a more advanced degree of nerve entrapment at the time of surgery.^\[[@R10]\]^ Based on our article analysis, we found that lack of randomized-controlled trials or well-designed prospective studies makes it insufficient to compare the effect of nerve decompression procedures on pain relief and sensory restoration in the upper and lower extremities of DPN patients.

Although there have been multiple articles on surgery for the treatment of DPN, this systematic review consolidates the information from these studies. The findings from our review have shown the efficacy of those surgical procedures in relieving the neurologic symptoms and restoring the sensory deficits in DPN patients. As there are few high-quality randomized-controlled trials or well-designed prospective studies, more data are needed to elucidate the role of surgical procedures for DPN treatment in the future.
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